Clinical Trial 41066

Woodstock, GA 30189


Study Summary:

The purpose of this study is to determine if treatment with dempedoic acid (ETC-1002) versus placebo decreases the risk of cardiovascular events in patients who are statin intolerant


Qualified Participants Must:

• Age between 18 and 85 years
• History of, or at high risk for, cardiovascular disease (CVD) including coronary artery disease, symptomatic peripheral arterial disease, cerebrovascular atherosclerotic disease, or at high risk for a cardiovascular event
•Patient reported history of statin intolerance
• Men and nonpregnant, nolactating women
• Fasting blood LDL-cholesterol greater than 100 at screening


Qualified Participants May Receive:

Compensation for time and travel


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.